Avik Banerjee

Avik Banerjee

Auto-generated profile, based on publicly available information

Avik Banerjee

Department of Chemistry, University of Illinois at Chicago, Chicago, IL 60607, USA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 December 2015 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
HJHyunbum Jang
Hyunbum Jang
ABAvik Banerjee
Avik Banerjee
TCTanmay S. Chavan
Tanmay S. Chavan
SLShaoyong Lu
Shaoyong Lu
JZJian Zhang
Jian Zhang
Ruth NussinovRuth Nussinov
Ruth Nussinov
Is nucleotide exchange sufficient to activate K‐Ras4B? To signal, oncogenic rat sarcoma (Ras) anchors in the membrane and recruits effectors by exposing its effector lobe. With the use of NMR and molecular dynamics (MD) simulations, we observed that in solution, farnesylated guanosine 5'‐diphosphate (GDP)‐bound K‐Ras4B is predominantly autoinhibited by its hypervariable region (HVR), whereas the GTP‐bound state favors an activated, HVR‐released state. On the anionic membrane, the catalytic domain adopts multiple orientations, including parallel (~180°) and perpendicular (~90°) alignments of the allosteric helices, with respect to the membrane surface direction. In the autoinhibited state, the HVR is sandwiched between the effector lobe and the membrane; in the active state, with membrane‐anchored farnesyl and unrestrained HVR, the catalytic domain fluctuates reinlessly, exposing its effector‐binding site. Dimerization and clustering can reduce the fluctuations. This achieves preorganized, productive conformations. Notably, we also observe HVR‐autoinhibited K‐Ras4B‐GTP states, with GDP‐bound‐like orientations of the helices. Thus, we propose that the GDP/GTP exchange may not be sufficient for activation; instead, our results suggest that the GDP/GTP exchange, HVR sequestration, farnesyl insertion, and orientation/localization of the catalytic domain at the membrane conjointly determine the active or inactive state of K‐Ras4B. Importantly, K‐Ras4B‐GTP can exist in active and inactive states; on its own, GTP binding may not compel K‐Ras4B activation.—Jang, H., Banerjee, A., Chavan, T. S, Lu, S., Zhang, J., Gaponenko, V., Nussinov, R. The higher level of complexity of K‐Ras4B activation at the membrane. FASEB J. 30, 1643–1655 (2016). www.fasebj.org

1 April 2018 in Developmental Cell
Verified
Journal Article
Closed access
DPDean J. Procter
Dean J. Procter
ABAvik Banerjee
Avik Banerjee
MNMasatoshi Nukui
Masatoshi Nukui
KKKevin Kruse
Kevin Kruse
VGVadim Gaponenko
Vadim Gaponenko
DWDerek Walsh
Derek Walsh

1 November 2015 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
SLShaoyong Lu
Shaoyong Lu
ABAvik Banerjee
Avik Banerjee
HJHyunbum Jang
Hyunbum Jang
JZJian Zhang
Jian Zhang
VGVadim Gaponenko
Vadim Gaponenko
Ruth NussinovRuth Nussinov
Ruth Nussinov
K-Ras4B, a frequently mutated oncogene in cancer, plays an essential role in cell growth, differentiation, and survival. Its C-terminal membrane-associated hypervariable region (HVR) is required for full biological activity. In the active GTP-bound state, the HVR interacts with acidic plasma membrane (PM) headgroups, whereas the farnesyl anchors in the membrane; in the inactive GDP-bound state, the HVR may interact with both the PM and the catalytic domain at the effector binding region, obstructing signaling and nucleotide exchange. Here, using molecular dynamics simulations and NMR, we aim to figure out the effects of nucleotides (GTP and GDP) and frequent (G12C, G12D, G12V, G13D, and Q61H) and infrequent (E37K and R164Q) oncogenic mutations on full-length K-Ras4B. The mutations are away from or directly at the HVR switch I/effector binding site. Our results suggest that full-length wild-type GDP-bound K-Ras4B (K-Ras4BWT-GDP) is in an intrinsically autoinhibited state via tight HVR-catalytic domain interactions. The looser association in K-Ras4BWT-GTP may release the HVR. Some of the oncogenic mutations weaken the HVR-catalytic domain association in the K-Ras4B-GDP/-GTP bound states, which may facilitate the HVR disassociation in a nucleotide-independent manner, thereby up-regulating oncogenic Ras signaling. Thus, our results suggest that mutations can exert their effects in more than one way, abolishing GTP hydrolysis and facilitating effector binding.

1 December 2015 in Biophysical Journal
Verified
Journal Article
Open access
TCTanmay S. Chavan
Tanmay S. Chavan
HJHyunbum Jang
Hyunbum Jang
LKLyuba Khavrutskii
Lyuba Khavrutskii
SASherwin J. Abraham
Sherwin J. Abraham
ABAvik Banerjee
Avik Banerjee
NTNadya I. Tarasova
Nadya I. Tarasova
Ras proteins are small GTPases that act as signal transducers between cell surface receptors and several intracellular signaling cascades. They contain highly homologous catalytic domains and flexible C-terminal hypervariable regions (HVRs) that differ across Ras isoforms. KRAS is among the most frequently mutated oncogenes in human tumors. Surprisingly, we found that the C-terminal HVR of K-Ras4B, thought to minimally impact the catalytic domain, directly interacts with the active site of the protein. The interaction is almost 100-fold tighter with the GDP-bound than the GTP-bound protein. HVR binding interferes with Ras-Raf interaction, modulates binding to phospholipids, and slightly slows down nucleotide exchange. The data indicate that contrary to previously suggested models of K-Ras4B signaling, HVR plays essential roles in regulation of signaling. High affinity binding of short peptide analogs of HVR to K-Ras active site suggests that targeting this surface with inhibitory synthetic molecules for the therapy of KRAS-dependent tumors is feasible.

1 March 2017 in Trends in Cancer
Verified
Journal Article
Closed access
Ruth NussinovRuth Nussinov
Ruth Nussinov
GWGuanqiao Wang
Guanqiao Wang
CTChung-Jung Tsai
Chung-Jung Tsai
HJHyunbum Jang
Hyunbum Jang
SLShaoyong Lu
Shaoyong Lu
VGVadim Gaponenko
Vadim Gaponenko

2 October 2018 in Science Signaling
Verified
Journal Article
Closed access
PDF file
MBMarco Biancucci
Marco Biancucci
GMGeorge Minasov
George Minasov
ABAvik Banerjee
Avik Banerjee
AHAlfa Herrera
Alfa Herrera
PWPatrick J. Woida
Patrick J. Woida
KSKarla J. F. Satchell
Karla J. F. Satchell
The Ras–extracellular signal–regulated kinase pathway is critical for controlling cell proliferation, and its aberrant activation drives the growth of various cancers. Because many pathogens produce toxins that inhibit Ras activity, efforts to develop effective Ras inhibitors to treat cancer could be informed by studies of Ras inhibition by pathogens. Vibrio vulnificus causes fatal infections in a manner that depends on multifunctional autoprocessing repeats-in-toxin, a toxin that releases bacterial effector domains into host cells. One such domain is the Ras/Rap1-specific endopeptidase (RRSP), which site-specifically cleaves the Switch I domain of the small GTPases Ras and Rap1. We solved the crystal structure of RRSP and found that its backbone shares a structural fold with the EreA/ChaN-like superfamily of enzymes. Unlike other proteases in this family, RRSP is not a metalloprotease. Through nuclear magnetic resonance analysis and nucleotide exchange assays, we determined that the processing of KRAS by RRSP did not release any fragments or cause KRAS to dissociate from its bound nucleotide but instead only locally affected its structure. However, this structural alteration of KRAS was sufficient to disable guanine nucleotide exchange factor–mediated nucleotide exchange and prevent KRAS from binding to RAF. Thus, RRSP is a bacterial effector that represents a previously unrecognized class of protease that disconnects Ras from its signaling network while inducing limited structural disturbance in its target.